Glen Liszczak  laboratory is exploring cellular signaling mechanisms that regulate transcription and preserve genome stability.

The overarching goal of Wen-hong Li Lab is to investigate mechanisms responsible for maintaining islet cell function and to devise new strategies for enhancing beta cell fitness and robustness to prevent or treat diabetes.

The Smith Lab strives to develop enabling tools for organic synthesis, allowing bioactive molecules of great complexity to be prepared in a concise and sustainable fashion.

The ultimate goal of the Nijhawan-De Branander Lab is to discover first in class drugs for the treatment of cancer. 

The McFadden Lab uses genetically engineered mice and human cancer cells to identify new genes and small molecules that regulate cancer cell growth.

The broad research interest of Fei Wang lab is in dissecting molecular mechanisms of essential membrane-associated cellular events in eukaryotic cell development.

The Orth lab is interested in elucidation the activity of virulence factors from pathogenic bacteria so that we can gain novel molecular insight into eukaryotic signaling systems.

Our laboratory is interested in investigating the molecular mechanisms of selenoproteins in health and disease.

We are interested in how membrane cholesterol controls diverse cellular signaling pathways to ensure lipid homeostasis, enable cell growth, and protect against infections. 

The Tambar Group develops new strategies and concepts in synthetic chemistry to address challenging problems in chemistry and biology.